Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) - Total assets
Total assets on the balance sheet as of December 2023 : $0.12 B
According to Y-mAbs Therapeutics 's latest financial reports the company's total assets are $0.12 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Y-mAbs Therapeutics - Total assets on balance sheet (from 2017 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | -9.61% |
| 2022-12-31 | $0.14 B | -33.52% |
| 2021-12-31 | $0.21 B | 61.14% |
| 2020-12-31 | $0.13 B | -38.97% |
| 2019-12-31 | $0.21 B | 42.42% |
| 2018-12-31 | $0.15 B | 64.91% |
| 2017-12-31 | $92.12 M | 433.73% |
| 2016-12-31 | $17.26 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | 97.08% | 🇺🇸 USA |